It has been stated that a decrease in PON-1 activity occurs in cases of high oxidative stress states, such as metabolic syndrome, obesity, uncontrolled diabetes, cardiovascular disorders, and fatty liver disease [37,38,39]. Here, PON1 is linked to fatty liver disease.